A patent granted to George Mason University Research Foundation Inc., which describes a novel treatment method for pre-invasive breast cancer, has been exclusively licensed to Targeted Pharmaceuticals LLC, a clinical-stage biopharmaceutical company focused on utilizing cannabinoids for the treatment of oncology and central nervous system disorders.
{iframe}https://cos.gmu.edu/blog/2019/07/george-mason-university-patent-with-applications-to-breast-cancer-treatment-licensed-by-targeted-pharmaceuticals-a-cannabinoid-based-drug-discovery-company/#.XT8q7ZNKhTZ{/iframe}